Prospective Cohort With Hemopathy in Languedoc-Roussillon

Recruiting now

Conditions studied: Hematologic Malignancy

In brief

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.

Key facts

Study ID

NCT02134574

Run by

University Hospital, Montpellier

People needed

500

Starts

2014-02-01

Expected to finish

2033-06-01

Last updated by the study team

2026-06-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age over 18
• Consultant or hospitalized patient for suspected malignant hemopathy and justifying further exploration or patient with a diagnosis of malignant hemopathy less than 6 months old at the time of signing the consent
• Having signed an informed consent
• Affiliated with a social security scheme

You may not qualify if…

• Minor or major protected
• Patients who have received treatment for hematological pathology

Where it is running

• Hematology department - UHMontpellier Saint éloi — Montpellier, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.